The 2026 american society of clinical oncology (asco) meeting has featured discussions on bladder cancer and other genitourinary cancers. Experts have highlighted new approaches and developments in the field, including updates on urothelial carcinoma and potential cures for bladder and kidney cancers. The meeting has also sparked discussion among oncology professionals, with some describing the updates as "groundbreaking" while others note lingering questions.